Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matthew D. Kerr, David A. McBride, Arun K. Chumber & Nisarg J. Shah. (2021) Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer. Expert Opinion on Drug Discovery 16:1, pages 89-99.
Read now
Read now
Victoria A Brentville, Peter Symonds, Katherine W Cook, Ian Daniels, Tracy Pitt, Mohamed Gijon, Poonam Vaghela, Wei Xue, Sabaria Shah, Rachael L Metheringham & Lindy G Durrant. (2019) T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy. OncoImmunology 8:5.
Read now
Read now
Poulam M. Patel, Christian H. Ottensmeier, Clive Mulatero, Paul Lorigan, Ruth Plummer, Hardev Pandha, Somaia Elsheikh, Efthymios Hadjimichael, Naty Villasanti, Sally E. Adams, Michelle Cunnell, Rachael L. Metheringham, Victoria A. Brentville, Lee Machado, Ian Daniels, Mohamed Gijon, Drew Hannaman & Lindy G. Durrant. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology 7:6.
Read now
Read now
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Read now
Articles from other publishers (29)
Sabaria Shah, Katherine W Cook, Peter Symonds, Juliane Weißer, Anne Skinner, Abdullah Al Omari, Samantha J Paston, Ian Pike, Lindy G Durrant & Victoria A Brentville. (2023) Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity. Journal for ImmunoTherapy of Cancer 11:10, pages e006966.
Crossref
Crossref
Hong Zhou, Yipeng Ma, Fenglan Liu, Bin Li, Dongjuan Qiao, Peigen Ren & Mingjun Wang. (2023) Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment. Frontiers in Immunology 14.
Crossref
Crossref
David Hernán Martínez-Puente, José Juan Pérez-Trujillo, Laura Mireya Zavala-Flores, Aracely García-García, Arnulfo Villanueva-Olivo, Humberto Rodríguez-Rocha, Jesús Valdés, Odila Saucedo-Cárdenas, Roberto Montes de Oca-Luna & María de Jesús Loera-Arias. (2022) Plasmid DNA for Therapeutic Applications in Cancer. Pharmaceutics 14:9, pages 1861.
Crossref
Crossref
Ruhul H Choudhury, Peter Symonds, Samantha J Paston, Ian Daniels, Katherine W Cook, Mohamed Gijon, Rachael L Metheringham, Victoria A Brentville & Lindy G Durrant. (2022) PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy. Journal for ImmunoTherapy of Cancer 10:2, pages e003526.
Crossref
Crossref
Rui Bai & Cheng Yuan. (2022) Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen. Aging and disease 13:4, pages 1267.
Crossref
Crossref
Maria Tagliamonte & Gennaro Ciliberto. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
137
154
.
Divya Nagarajan, Joshua Pearson, Victoria Brentville, Rachael Metheringham, A Graham Pockley, Lindy Durrant & Stephanie E McArdle. (2021)
Helicase antigen (HAGE)‐derived vaccines induce immunity to HAGE and ImmunoBody®‐HAGE DNA vaccine delays the growth and metastasis of HAGE‐expressing tumors
in vivo
. Immunology & Cell Biology 99:9, pages 972-989.
Crossref
Crossref
Tayebeh Rezaei, Elham Davoudian, Saeed Khalili, Mohammad Amini, Maryam Hejazi, Miguel de la Guardia & Ahad Mokhtarzadeh. (2020) Strategies in DNA vaccine for melanoma cancer. Pigment Cell & Melanoma Research 34:5, pages 869-891.
Crossref
Crossref
Ping Yang, Mei Meng & Quansheng Zhou. (2021) Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188558.
Crossref
Crossref
Rukaia Almshayakhchi, Divya Nagarajan, Jayakumar Vadakekolathu, Barbara-Ann Guinn, Stephen Reeder, Victoria Brentville, Rachael Metheringham, A. Graham Pockley, Lindy Durrant & Stephanie McArdle. (2021) A Novel HAGE/WT1-ImmunoBody® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone. Frontiers in Oncology 11.
Crossref
Crossref
Samantha J. Paston, Victoria A. Brentville, Peter Symonds & Lindy G. Durrant. (2021) Cancer Vaccines, Adjuvants, and Delivery Systems. Frontiers in Immunology 12.
Crossref
Crossref
Erin G. Hartnett, Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards & Anda M. Vlad. (2020) Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers 12:12, pages 3733.
Crossref
Crossref
Afsheen Raza, Maysaloun Merhi, Varghese Philipose Inchakalody, Roopesh Krishnankutty, Allan Relecom, Shahab Uddin & Said Dermime. (2020) Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy. Journal of Translational Medicine 18:1.
Crossref
Crossref
Yuki Tanaka, Hiroshi Wada, Risa Goto, Toshihiro Osada, Keisuke Yamamura, Satoshi Fukaya, Atsushi Shimizu, Mitsuru Okubo, Kazuhisa Minamiguchi, Koichi Ikizawa, Eiji Sasaki & Teruhiro Utsugi. (2020) TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice. Scientific Reports 10:1.
Crossref
Crossref
Victoria A Brentville, Rachael L Metheringham, Ian Daniels, Suha Atabani, Peter Symonds, Katherine W Cook, Mireille Vankemmelbeke, Ruhul Choudhury, Poonam Vaghela, Mohamed Gijon, Ghislaine Meiners, Willem-Jan Krebber, Cornelis J M Melief & Lindy G Durrant. (2020) Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses. Journal for ImmunoTherapy of Cancer 8:1, pages e000560.
Crossref
Crossref
Alessandra Lopes, Gaëlle Vandermeulen & Véronique Préat. (2019) Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Grace Cole, Ahlam A. Ali, Emma McErlean, Eoghan J. Mulholland, Amy Short, Cian M. McCrudden, Joanne McCaffrey, Tracy Robson, Vicky L. Kett, Jonathan A. Coulter, Nicholas J. Dunne, Ryan F. Donnelly & Helen O. McCarthy. (2019) DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen. Acta Biomaterialia 96, pages 480-490.
Crossref
Crossref
Xiaoyi Sun, Linghui Zeng & Yongzhuo Huang. (2019) Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination. The Journal of Gene Medicine 21:7.
Crossref
Crossref
Hanjiao Qin, Jiyao Sheng, Dan Zhang, Xuewen Zhang, Linlin Liu, Bingjin Li, Guangquan Li & Zhuo Zhang. (2019) New Strategies for Therapeutic Cancer Vaccines. Anti-Cancer Agents in Medicinal Chemistry 19:2, pages 213-221.
Crossref
Crossref
Cao Dai Phung, Hanh Thuy Nguyen, Tuan Hiep Tran, Han-Gon Choi, Chul Soon Yong & Jong Oh Kim. (2019) Rational combination immunotherapeutic approaches for effective cancer treatment. Journal of Controlled Release 294, pages 114-130.
Crossref
Crossref
Gheath Alatrash, Alyssa K. Crain & Jeffrey J. Molldrem. 2019. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation
107
125
.
Anna Tessari, Lorenzo Pilla, Damian Silvia, Matteo Duca, Biagio Paolini, Maria Luisa Carcangiu, Luigi Mariani, Filippo G. de Braud & Sara Cresta. (2018) Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?. The Breast 42, pages 68-73.
Crossref
Crossref
Alessandra Lopes, Kevin Vanvarenberg, Špela Kos, Sophie Lucas, Didier Colau, Benoît Van den Eynde, Véronique Préat & Gaëlle Vandermeulen. (2018) Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma. Scientific Reports 8:1.
Crossref
Crossref
Galaxia Rodriguez, Kristianne Galpin, Curtis McCloskey & Barbara Vanderhyden. (2018) The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy. Cancers 10:8, pages 242.
Crossref
Crossref
Victoria A Brentville, Suha Atabani, Katherine Cook & Lindy G Durrant. (2018) Novel tumour antigens and the development of optimal vaccine design. Therapeutic Advances in Vaccines and Immunotherapy 6:2, pages 31-47.
Crossref
Crossref
Katherine Cook, Lindy Durrant & Victoria Brentville. (2018) Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 6:2, pages 37.
Crossref
Crossref
Peter L. Stern. (2017) Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12–13 May 2017. Therapeutic Advances in Vaccines 5:3, pages 55-68.
Crossref
Crossref
Wei Xue, Victoria A. Brentville, Peter Symonds, Katherine W. Cook, Hideo Yagita, Rachael L. Metheringham & Lindy G. Durrant. (2016) SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors. Oncotarget 7:50.
Crossref
Crossref
Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard & Eric Tartour. (2016) Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors. Vaccines 4:4, pages 37.
Crossref
Crossref